Fred E. Cohen
Independent DirectorDr. Fred E. Cohen, D.Phil., FACP, M.D., Ph.D., is Director of Autobahn Therapeutics, Inc. from August 2026. Dr. Cohen is Director of Ascend Gene and Cell Therapies LLC. He is Director of Aptalis Holdings Inc. from February 2008. Dr. Cohen joined the Aptalis Holdings Inc. in February 2008. Dr. Cohen is Independent Director of Intellia Therapeutics, Inc. from January 24, 2019. Dr. Cohen is Independent Director of CareDx, Inc from January 2003. Dr. Cohen joined the CareDx, Inc in January 2003. Dr. Cohen is Member of Scientific Advisory Board of Functional Genetics, Inc. Dr. Cohen is Director of Novotech (Australia) Pty Limited. Dr. Cohen is Member of Scientific Advisory Board of Pediatric Bioscience, Inc. Dr. Cohen was Independent Director of Progyny, Inc. from March 2015 to May 22, 2025. Dr. Cohen is Chairman of Cell Design Labs, Inc. Dr. Cohen is Director of Precision Medicine Group, LLC from June 2023. Dr. Cohen is Director of ProLynx Inc. Dr. Cohen is Co-founder & Senior Advisor of Vida Ventures Advisors, LLC from 2022. Dr. Cohen was Co-founder, Senior MD & Senior Advisor of Vida Ventures Advisors, LLC until 2022. Dr. Cohen was Co-Founder & Senior MD of Vida Ventures Advisors, LLC. Dr. Cohen is Independent Director of Kyverna Therapeutics, Inc. from September 2018. Dr. Cohen was Chairman of Kyverna Therapeutics, Inc. from January 13, 2020 to September 2021. Dr. Cohen is Partner & Chairman of Monograph Capital. Dr. Cohen is Chairman & Partner of Monograph Capital Partners. Dr. Cohen is Board Member of Human Immunology Biosciences, Inc. Dr. Cohen is Director of Ascend Gene & Cell Therapies Ltd. Dr. Cohen was Chairman of the Board of Ascend Gene & Cell Therapies Ltd. Dr. Cohen is Director of Ollin Biosciences, Inc. Dr. Cohen is Founder of Monograph Capital Advisors, L.P. Dr. Cohen was Partner and Senior Advisor of TPG Capital, L.P. Dr. Cohen was Partner and Managing Director of TPG Biotech. Dr. Cohen was Partner and Managing Director of TPG Growth, LLC. Dr. Cohen focused on Life Sciences. Dr. Cohen was Independent Director of Veracyte, Inc. from January 2007 to June 07, 2021. Dr. Cohen was employed at Veracyte, Inc. from January 2007 to June 07, 2021. Dr. Cohen was Director of IQVIA Holdings Inc. Dr. Cohen was employed at IQVIA Holdings Inc. from May 08, 2007 to November 05, 2015. Dr. Cohen was Independent Director of Tandem Diabetes Care, Inc. from June 2013 to June 18, 2019. Dr. Cohen was employed at Tandem Diabetes Care, Inc. from June 2013 to June 18, 2019. Dr. Cohen was Director of Five Prime Therapeutics, Inc. until May 10, 2018. Dr. Cohen was employed at Five Prime Therapeutics, Inc. from May 2002 to May 10, 2018. Dr. Cohen was Independent Director of Genomic Health, Inc. from April 01, 2002 to November 08, 2019. Dr. Cohen was employed at Genomic Health, Inc. from April 01, 2002 to November 08, 2019. Dr. Cohen was Director of BioCryst Pharmaceuticals, Inc. from July 2013 to January 04, 2019. Dr. Cohen was employed at BioCryst Pharmaceuticals, Inc. from July 23, 2013 to January 04, 2019. Dr. Cohen was Director of Roka Bioscience, Inc. until 2017. Dr. Cohen was Director of Roka Bioscience, Inc. from September 2009 to October 2017. Dr. Cohen was employed at Roka Bioscience, Inc. from September 2009 to 2017. Dr. Cohen was Director of DoubleTwist, Inc. Dr. Cohen joined the DoubleTwist, Inc. in February 1997. Dr. Cohen was Director of Kémia, Inc. Dr. Cohen was Director of Rapid Micro Biosystems, Inc. Dr. Cohen was Director of Asklepios BioPharmaceutical, Inc. Dr. Cohen was Director of Anaborex, Inc. Dr. Cohen was Director of Nodality Inc. Dr. Cohen was Director of ProteoGenix, Inc. Dr. Cohen was Director of CardioDx, Inc. Dr. Cohen was employed at CardioDx, Inc. from July 2003 to April 30, 2010. Dr. Cohen was Independent Director of UroGen Pharma Ltd. from May 16, 2017 to September 12, 2024. Dr. Cohen was employed at UroGen Pharma Ltd. from May 16, 2017 to September 12, 2024. Dr. Cohen was Member of Advisory Board of CHV Capital, Inc. Dr. Cohen was Director of Mylan Laboratories Limited. Dr. Cohen was employed at Mylan Laboratories Limited until July 14, 2014. Dr. Cohen was Executive Officer of Sparks Marketing Group, Inc. Dr. Cohen has M.D. from Stanford University in 1984, B.S. in Biochemistry & Molecular Biophysics from Yale University in 1978, Ph.D. in Molecular Biophysics from University of Oxford in 1980.
Positions
- Company NameCareDx, Inc.Stock CodeCDNAPositionIndependent DirectorColleagues
- JWJohn Walter HannaPresident, CEO & Director
- MDMichael D. GoldbergIndependent Chairman
- KSKeith S. KennedyCFO & COO
- JAJeffrey A. NovackGeneral Counsel & Secretary
- JMJessica MengChief Commercial Officer
- KRKashif RathoreChief Technology Officer
- CMChristine M. CournoyerIndependent Director
- RBR. Bryan RiggsbeeIndependent Director
